发明名称 |
csPCNA Isoform Antibodies And Uses Thereof |
摘要 |
Antibodies specifically bind only to a cancer specific proliferating cell nuclear antigen (csPCNA) isoform and not to the non-malignant proliferating cell nuclear antigen (nmPCNA) isoform. Methods and compositions to detect the presence of csPCNA isoform are disclosed. |
申请公布号 |
US2015259407(A1) |
申请公布日期 |
2015.09.17 |
申请号 |
US201514645498 |
申请日期 |
2015.03.12 |
申请人 |
MALKAS Linda H. |
发明人 |
HICKEY Robert J.;MALKAS Linda H.;SCHNAPER Lauren |
分类号 |
C07K16/18;G01N33/574;A61K9/127;A61K45/06;A61K39/395 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for reducing tumor progression in a subject, comprising:
administering a pharmaceutically acceptable composition comprising a formulation of a therapeutically effective amount of cancer specific proliferating cell nuclear antigen (csPCNA) isoform-specific antibody that specifically binds cancer specific proliferating cell nuclear antigen (csPCNA) isoform, wherein the antibody does not bind to non-malignant proliferating cell nuclear antigen (nmPCNA), and wherein the antibody binds to an epitope of csPCNA comprising an amino acid sequence selected from LGIPEQEY (SEQ ID NO: 1), QLGIPEQEY (SEQ ID NO: 9), LGIPEQEYSCVV (SEQ ID NO: 13), LGIPEQEYSCV (SEQ ID NO: 14), and LGIPEQEYSC (SEQ ID NO: 15); and a delivery component to an individual having a tumor. |
地址 |
US |